Feedback of the companies present at the ODDO BHF Nextcap Forum Company Country Market cap. (m) Company Country Market cap. (m) Accsys Technologies € 124 Hoffmann Green € 62 Afyren € 72 Hornbach € 1 451 Altri € 1 058 IDI € 537 AMG € 550 Implenia CHF 973 AmRest PLN 3 544 Jacquet Metals € 494 Arcure € 29 Kloeckner & Co € 653 Arverne 194 Knaustabbert € 144 Austriacard Holdings € 188 Lna Santé € 270 Bastide € 218 Medincell € 398 Befesa € 1 116 Nacon € 63 CAF € 1 649 N...
Our 14th edition of the ODDO BHF Nextcap Forum took place on 11 June in Paris, and on 12 June virtually. 96 companies and 170 investors were present for more than 700 meetings organized. Overall, we noted a still cautious tone from companies, with limited visibility on a solid rebound in a persistently uncertain market environment (geopolitical situation, US politics, etc.), even if there are some signs of recovery and certain sectors remain very well positioned (leisure, energy, defence). At th...
EQS-News: Afyren SAS / Key word(s): Personnel AFYREN strengthens its Executive Committee with appointment of Laurent Pou as Industrial Director 10.04.2025 / 07:40 CET/CEST The issuer is solely responsible for the content of this announcement. AFYREN strengthens its Executive Committee with appointment of Laurent Pou as Industrial Director Further strengthening of the executive committee with industrial skills to support the final start-up phase of AFYREN NEOXY Clermont-Ferrand/Lyon, 10 April 2025 at 07:30 CEST – AFYREN a greentech company offering manufacturers biobased...
EQS-News: Afyren SAS / Key word(s): Annual Results AFYREN announces its 2024 full-year financial results 27.03.2025 / 07:40 CET/CEST The issuer is solely responsible for the content of this announcement. AFYREN announces its 2024 full-year financial results Operational progress towards continuous production Intensification of production campaigns in 2024 and early 2025 Production and marketing of several dozen tons of acids Validation of product quality delivered to customers and prospects Good cost control and financial support to AFYREN NEOXY start-up phase ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.